Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Split-dosing versus non-split dosing of ergocalciferol in chronic kidney disease patients
TCTR20190830003Recruiting
- Sponsor
- Phramongkutklao Hospital
- Start
- Aug 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised trial of vitamin d in chronic kidney disease (CKD) and Vitamin D deficiency (VDD) (2 arms), sponsored by Phramongkutklao Hospital. Primary endpoint: Change in serum 25-hydroxyvitamin D. Started Aug 2019; status: recruiting.
02
Drugs
vitamin d
03
Conditions
chronic kidney disease (CKD)Vitamin D deficiency (VDD)
Beyond the preview
Go deeper on TCTR20190830003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20190830003.